The reiteration of the 'Sector Perform' rating and the maintained price target by RBC Capital indicates that the analyst sees the stock performing in line with the expectations. This is neither a positive nor a negative signal, hence the neutral score. The relevance is high as the news directly pertains to Regenxbio. The importance is moderate as analyst ratings can influence investor sentiment but are not the only factor. The confidence is high as the information is clear and direct.